This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coutant, R. Articles by Limal, J. M. Search for Related Content PubMed PubMed Citation Articles by Coutant, R. Articles by Limal, J. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diets Growth Disorders Hazardous Substances DB ETHINYLESTRADIOL TESTOSTERONE

Body Composition, Fasting Leptin, and Sex Steroid Administration Determine GH Sensitivity in Peripubertal Short Children

Departments of Pediatrics (R.C., S.R., J.M.L.), Nuclear Medicine (F.B.d.C.), Biochemistry A (O.D.), Biochemistry B (E.M.), and Rheumatology (M.A.), University Hospital, 49000 Angers, France

Address all correspondence and requests for reprints to: Dr. Régis Coutant, Department of Pediatrics, University Hospital, 4 rue Larrey, 49000 Angers, France. E-mail: recoutant{at}chu-angers.fr

Abstract

Serum IGF-I levels in GH-treated subjects demonstrate a wide range of responsiveness to GH. However, the factors influencing GH sensitivity are not well known. The aim of this work was 1) to test whether body composition (determined by dual energy x-ray absorptiometry) or factors related to body composition (fasting blood glucose, FFA, C-peptide, leptin, and insulin sensitivity determined by an insulin tolerance test) influence GH sensitivity; and 2) to study the effect of sex steroid priming on GH sensitivity. We measured serum IGF-I at baseline and 24 h after a single administration of GH (2 mg/m²) in 60 healthy prepubertal and early pubertal children (height, -2.1 ± 1.0 SD score). GH sensitivity, as estimated by the increase in serum IGF-I after GH administration (difference between stimulated and baseline serum IGF-I = IGF-I), was also determined after a short-term administration of oral ethinyl E2 in girls and im T in boys.

The serum IGF-I concentration was 297 ± 114 µg/liter at baseline and increased to 429 ± 160 µg/liter, corresponding to a 46 ± 29% increase over the baseline value (P < 0.0001, stimulated vs. baseline serum IGF-I). IGF-I was not different between gender or pubertal stage. There were positive correlations (P < 0.001) between IGF-I and adiposity (total body fat, r = 0.62; trunk fat, r = 0.62), fasting leptin (r = 0.64), and C-peptide (r = 0.54), and a negative correlation with fasting FFA (r = -0.33; P < 0.05) even after adjustment for age, gender, and pubertal stage. These factors remained significant independent predictors of the absolute as well as the percent increase in serum IGF-I in multiple regression analyses. Priming with T and ethinyl E2 had a similar stimulating effect on the serum GH peak in response to the insulin tolerance test. In boys, serum baseline IGF-I increased by 60%, and IGF-I was similar after vs. before T administration. By contrast, in girls, serum baseline IGF-I was similar, and IGF-I was 60% less after vs. before ethinyl E2 administration.

This study indicates that 1) GH sensitivity is determined by fat mass, serum fasting leptin, C-peptide, and FFA; and 2) oral ethinyl E2 and im T have divergent effects on the IGF-I response to a single administration of GH.

This article has been cited by other articles:

				N. Bouhours-Nouet, F. Gatelais, F. Boux de Casson, S. Rouleau, and R. Coutant The Insulin-Like Growth Factor-I Response to Growth Hormone Is Increased in Prepubertal Children with Obesity and Tall Stature J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 629 - 635. [Abstract] [Full Text] [PDF]